Literature DB >> 27809669

Polymorphisms of Cytokine Genes and Polycystic Ovary Syndrome: A Review.

Josiane Bazzo de Alencar1, Hugo Vicentin Alves1, Laise Nayana Sala Elpidio1, Jeane Eliete Laguila Visentainer1,2, Ana Maria Sell1.   

Abstract

BACKGROUND: Polycystic ovary syndrome (PCOS) is the endocrinopathy that affects women in their reproductive age. The physiopathology involves multifactorial mechanisms, including cytokine gene regulation.
METHODS: The review was conducted in the database PubMed, with articles published between 2005 and 2015. The selected studies evaluated the single-nucleotide polymorphisms (SNPs) of cytokines genes in association with PCOS. Twenty-four studies met the inclusion criteria and showed the SNPs of cytokines that were associated or not with PCOS.
RESULTS: The disease susceptibility was associated with interleukin (IL) 1A, IL1B, IL1RN, and IL6 alleles and genotypes. The tumor necrosis factor (TNF) -1032 C/T genotype and C allele were risk factors and T/T genotype was a protector marker to disease. The IL18 SNPs were not associated with PCOS per se, but IL18-137 C and G alleles were related to the protection of insulin resistance and glucose tolerance, respectively. One research found association between TGFB1 and PCOS. However, the TNF -308, IL10, and interferon (IFN) SNPs did not appear to influence PCOS genetic susceptibility.
CONCLUSIONS: This study sought to contribute and clarify the SNPs in cytokine genes that influence the development of PCOS. Most studies occurred in Asia; most SNPs studied were in IL1B -511, TNF -1031, and IL6-174; and most of them were associated with the susceptibility to PCOS development. Nevertheless, further investigations based on genome-wide association studies and cytokine gene SNPs are needed to better characterize the risk factors to PCOS.

Entities:  

Keywords:  SNP; cytokines; genetic polymorphisms; polycystic ovary syndrome

Mesh:

Substances:

Year:  2016        PMID: 27809669     DOI: 10.1089/met.2016.0101

Source DB:  PubMed          Journal:  Metab Syndr Relat Disord        ISSN: 1540-4196            Impact factor:   1.894


  3 in total

1.  Association between VEGF gene polymorphisms (11 sites) and polycystic ovary syndrome risk.

Authors:  Li Huang; Lunwen Wang
Journal:  Biosci Rep       Date:  2020-03-27       Impact factor: 3.840

2.  Association of IL-1β, IL-6, TNF-α, and TGFβ1 Gene Polymorphisms with Recurrent Spontaneous Abortion in Polycystic Ovary Syndrome.

Authors:  Afrah F Alkhuriji; Suliman Y Al Omar; Zainb A Babay; Manal F El-Khadragy; Lamjed A Mansour; Wazirah G Alharbi; Mahmoud I Khalil
Journal:  Dis Markers       Date:  2020-05-05       Impact factor: 3.434

3.  A network pharmacology approach to explore the mechanisms of Erxian decoction in polycystic ovary syndrome.

Authors:  Lihong Liu; Bo Du; Haiying Zhang; Xiaofei Guo; Zheng Zhou; Aihui Xiu; Chang Liu; Shiyu Su; Hao Ai
Journal:  Chin Med       Date:  2018-08-29       Impact factor: 5.455

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.